Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.

Haleon plc American Depositary Shares (Each representing two)

In a report released on November 11, Karel Zoete from Kepler Capital maintained a Buy rating on Haleon PLC, with a price target of p430.00. The com...

Haleon PLC (HLN) Gets a Buy from Kepler Capital

Highland Critical Minerals Corp. ( ($TSE:HLND) ) has issued an announcement. Highland Critical Minerals Corp. announced that it is unaware of any m...

Highland Critical Minerals Corp. Addresses Market Activity and Strategic Developments

An announcement from Highland Critical Minerals Corp. ( ($TSE:HLND) ) is now available. Highland Critical Minerals Corp. has entered into a binding...

Highland Critical Minerals Corp. to Acquire Nunavut Mining Claims

In a report released yesterday, Bethan Davies from Berenberg Bank reiterated a Buy rating on Haleon PLC, with a price target of p517.00. According ...

Berenberg Bank Keeps Their Buy Rating on Haleon PLC (HLN)

In a report released today, Warren Ackerman from Barclays maintained a Hold rating on Haleon PLC, with a price target of £3.80. The company’s share...

Barclays Remains a Hold on Haleon PLC (HLN)

In a report released today, David Hayes from Jefferies maintained a Buy rating on Haleon PLC, with a price target of p440.00. The company’s shares ...

Jefferies Sticks to Their Buy Rating for Haleon PLC (HLN)

Haleon PLC ( ($GB:HLN) ) has issued an update. Haleon PLC announced that as of October 31, 2025, it has issued a total of 8,952,353,648 ordinary sh...

Haleon PLC Updates Total Voting Rights and Share Capital

Kepler Capital analyst Karel Zoete maintained a Buy rating on Haleon PLC on October 30 and set a price target of p430.00. The company’s shares clos...

J.P. Morgan analyst Celine Pannuti CFA reiterated a Sell rating on Haleon PLC today. The company’s shares closed today at p355.70. According to Tip...

Haleon PLC (HLN) Gets a Sell from J.P. Morgan

Highland Critical Minerals Corp. ( ($TSE:HLND) ) has issued an update. Highland Critical Minerals Corp. announced the receipt of an interim order f...

Highland Critical Minerals Corp. Seeks Shareholder Approval for Strategic Arrangement

Haleon PLC (($GB:HLN)) announced an update on their ongoing clinical study. Haleon PLC is conducting a clinical study titled ‘A 12-Week Randomized,...

Market Cap	$43.13B	P/E Ratio	20.56
52W High	$11.42	52W Low	$8.71
Div Yield	11.7%	Payout Ratio	N/A
EPS Growth 3Y	0.0%	52W Position	42.8%
Overall Score	83	Value Score	--
Quality Score	--	Technical Score	83

EPS Current Est	$0.48	EPS Next Est	$0.53
EPS Growth Est	+10.4%	DPS Growth 3Y	0.0%

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HLN	$9.87	+2.81%	9.94M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HLN	$9.87	+2.8%	9.94M
3
4
5
6

HLN

HLN

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get Haleon plc American Depositary Shares (Each representing two) Data in Excel

Get Haleon plc American Depositary Shares (Each representing two) Data in Excel